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Canonical Wnt signaling has been impli-
cated in various aspects of hematopoi-
esis. Its role is controversial due to differ-
ent outcomes between various inducible
Wnt-signaling loss-of-function models
and also compared with gain-of-function
systems. We therefore studied a mouse
deficient for a Wnt gene that seemed to
play a nonredundant role in hematopoi-
esis. Mice lacking Wnt3a die prenatally
around embryonic day (E) 12.5, allowing
fetal hematopoiesis to be studied using in
vitro assays and transplantation into irra-
diated recipient mice. Here we show that
Wnt3a deficiency leads to a reduction in
the numbers of hematopoietic stem cells
(HSCs) and progenitor cells in the fetal
liver (FL) and to severely reduced recon-
stitution capacity as measured in second-
ary transplantation assays. This defi-
ciency is irreversible and cannot be
restored by transplantation into Wnt3a
competent mice. The impaired long-term
repopulation capacity of Wnt3a/ HSCs
could not be explained by altered cell
cycle or survival of primitive progenitors.
Moreover, Wnt3a deficiency affected my-
eloid but not B-lymphoid development at
the progenitor level, and affected imma-
ture thymocyte differentiation. Our re-
sults show that Wnt3a signaling not only
provides proliferative stimuli, such as for
immature thymocytes, but also regulates
cell fate decisions of HSC during hemato-
poiesis. (Blood. 2009;113:546-554)
Introduction
Hematopoietic stem cells (HSCs) are responsible for the continu-
ous production of blood cells and consequently help to sustain
immune function. This is achieved by their unique capacity to
self-renew and ability to differentiate into all blood lineages.
Several studies have implicated the Wnt-signaling pathway in the
regulation of these processes, but its exact role is still not
completely understood.1,2
Upon binding of a Wnt protein to a Frizzled receptor and to a
LRP5/6 coreceptor, an elaborate signaling route leads to cytoplas-
matic accumulation and subsequent nuclear translocation of -
catenin, the key mediator of the Wnt-signaling pathway. In the
absence of a Wnt protein, the levels of -catenin are kept very low
by the action of the so-called destruction complex consisting of the
casein kinase I (CKI) and glycogen synthase kinase 3 (GSK-3)
serine/threonine kinases, the tumor suppressor protein adenoma-
tous polyposis coli (APC) and the scaffolding protein Axin.
Phosphorylation of -catenin by CKI and GSK-3 leads to its
ubiquitination and subsequent breakdown in the proteossome.
Activation of the Wnt pathway by a Wnt ligand results in
inactivation of GSK-3 and consequent translocation of -catenin
to the nucleus. In the nucleus, -catenin binds to members of the
Tcf/Lef transcription factors family, thereby converting these
proteins from transcriptional repressors into transcriptional
activators.3
The first evidence for a role of Wnt proteins in hematopoiesis
was reported in studies showing that stromal cell lines transduced
with Wnt1, Wnt5a, and Wnt10b have an in vitro stimulatory effect
on mouse4 and human5 hematopoietic progenitors.
Using Tcf1/Lef-GFP reporter assays, Wnt signaling was shown
to be active in the highly HSCs enriched LinSca1c-Kit (LSK)
population, both in vivo as well as in vitro after stimulation with
purified Wnt3a.6 Furthermore, Wnt3a treatment in vitro resulted in
increased proliferation of LSK cells along with the maintenance of
an immature phenotype and led to increased self-renewal as
determined by transplantation assays.7 Retroviral expression of a
constitutively active form of -catenin in Bcl2-transgenic LSK
cells resulted in augmented multilineage repopulation capacity. In
agreement, ectopic expression of the Wnt-signaling inhibitor Axin
yielded opposite results.6 However, subsequent gain- and loss-of-
function approaches to further elucidate the role of Wnt signaling
in HSCs yielded contradictory results. Two independent studies
using a conditional mouse model to express a stabilized form of
-catenin showed impaired multilineage differentiation and a
transient increase in stem cell numbers, followed by exhaustion of
the HSC pool, observed by failure to repopulate lethally irradiated
recipients.8,9 Therefore, the role of Wnt signaling in HSC biology is
currently controversial. Besides this, reciprocal approaches to
conditionally inactivate -catenin in HSCs also showed contradic-
tory results and brought further controversy, with some of these
studies showing normal hematopoiesis and stem cell activity in the
combined absence of -catenin and its homologue plakoglobin.10-13
These issues are reviewed in more detail elsewhere.14
The functions of several Wnt genes have been investigated by
targeted mutations in the mouse. These led to specific developmen-
tal defects, which are lethal early during embryonic development or
shortly after birth. Mice carrying a null allele of Wnt3a have been
generated by McMahon and coworkers. Wnt3a homozygous mu-
tant embryos die around embryonic day (E) 12.5 of the embryonic
development. These embryos lack caudal somites, have disrupted
notochords and exhibit anomalies of the central nervous system.15
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The hematopoietic system of these embryos has not been studied
yet. However, the fact that Wnt3a promotes proliferation of HSCs7
and pro-B cells,16 and the high expression in the thymic stroma17
make the Wnt3a gene of interest. In addition, Wnt3a/ embryos
are morphologically highly similar to Tcf1/Lef1 double-deficient
embryos,18,19 suggesting comparable defects in the hematopoietic
system20 of both strains. For these reasons we decided to investi-
gate the hematopoietic system of Wnt3a/ embryos.
Here we demonstrate that Wnt3a deficiency leads to a reduction
in the numbers of hematopoietic stem and progenitor cells in the
fetal liver (FL). Besides this, HSCs are functionally affected as
purified LSK cells show severely reduced reconstitution capacity
measured by secondary transplantation assays. This deficiency is
irreversible since transplantation into wild-type (Wt) recipient mice
could not restore HSC function, suggesting a role for Wnt3a in the
establishment of a HSC-specific genetic program. Moreover Wnt3a
deficiency affected myeloid but not lymphoid development at the
progenitor level and early stages of T-lymphoid development in the
thymus.
Our data provide genetic evidence for the involvement of a
specific Wnt protein in HSC self-renewal, suggesting that modula-
tion of Wnt signaling in stem cells or in their environment may be
beneficial for stem cell therapies, transplantation, and regenerative
medicine applications (Wilmington, MA).
Methods
Mice
Wnt3a heterozygous mice were bred and maintained in the Erasmus
Medical Center animal facility, in accordance with the legal regulations in
The Netherlands and with the approval of the Dutch animal ethical
committee, the DEC.
Mice heterozygous for the Wnt3a mutation were kindly provided by
T. Yamaguchi (National Cancer Institute-Frederick, Frederick, MD) and
were backcrossed to C57Bl/6. Genotyping was performed as described.15
To obtain Wnt3a/ embryos, Wnt3a heterozygous mice were put together
in the afternoon and checked for vaginal plug the next morning. The time at
which the vaginal plug was observed was considered E0.5. Embryos were
analyzed at E12.5. C57Bl/6-Ly5.1 mice were purchased from Charles River
Laboratories (Wilmington, MA).
Flow cytometry and cell sorting
For flow cytometric analyses and cell sorting, cells were stained with
monoclonal antibodies against the following molecules: B220 (Ra3-6B2),
CD3 (145-2C11), CD4 (L3T4), CD8 (53-6.7), CD11b/Mac1 (M1/70),
CD11c (HL3), CD19 (ID3), CD43 (S7), CD45.1/Ly5.1 (A20), CD45.2/
Ly5.2,(104) CD71 (C2), CD117/c-Kit (2B8), CD127/IL-7R (SB/199),
CD135/Flt3 (A2F10.1), F4/80 (BM8), GR1 (RB6-8C5), IgM (R6-60.2),
NK1.1 (PK136), Sca1 (E13-161.7) and Ter-119 all from Becton Dickinson/
Pharmingen (San Jose, CA); CD34 (RAM34) and FcRII/III(93) from
eBioscience (San Diego, CA); activated Notch1 (mN1A) from Abcam
(Cambridge, MA). Antibodies were used either directly conjugated or
biotinylated. For secondary detection streptavidin conjugated with PE-Cy7
or APC-Cy7 was used. 7AAD (Pharmingen) or DAPI (Invitrogen, Carls-
bad, CA)) were used for dead cells exclusion. Stained cells were measured
with a FACSCalibur and/or a FACSCanto, sorted on a FACSAria (Becton
Dickinson), and analyzed with FlowJo software (TreeStar, Ashland, OR).
To analyze LSK in FL, antibodies for lineage markers included B220, CD4,
CD11c, GR1, NK1.1 and Ter-119. When LSKs were analyzed in adult bone
marrow (BM) antibodies against CD11b (Mac1) and CD3 were added to the
lineage mix.
Cell cycle and apoptosis
Cell-cycle analysis of FL stem and progenitor cells was performed by
staining for 60 minutes 37°C with Hoechst 33342 ((Invitrogen/Molecular
Probes, Carlsbad, CA; 10 g/mL) in DMEM medium supplemented with
Verapamil inhibitor (Sigma-Aldrich, St Louis, MO; 10 M), 2% FBS and
1 mM HEPES (Invitrogen). Hoechst 33342 stained cells were than stained
with flow cytometry antibodies. To analyze the percentage of apoptotic cells
by flow cytometry, FL cells were stained with markers to define the LSK
population (see “Flow cytometry and cell sorting”) and subsequently
stained with FITC-conjugated annexin V and 7AAD (Becton Dickinson/
Pharmingen) according to the manufacturer’s instructions.
Transplantation experiments
For competitive transplantation assays, C57Bl/6 Ly5.1 recipient mice
(8-11 weeks old) were lethally irradiated (9.5 Gy). Four hundred sorted
LSKs (Ly5.2) from Wt or Wnt3a/ E12.5 FLs were mixed with 2.5  105
total Ly5.1 FL cells (E12.5) to obtain 1:1 competition and intravenously
injected in recipient mice. Repopulation, calculated as (percentage donor
cells)  100 / (percentage donor cells  percentage recipient cells), was
evaluated at 4, 8, 10, and 12 weeks after transplantation in peripheral blood
by flow cytometry. The mice were killed 12 weeks after transplantation. For
secondary transplantation, equal numbers of total BM cells from primary
recipients that received Wt or Wnt3a/ LSKs were pooled and trans-
planted into lethally irradiated Ly5.1 secondary recipients. Peripheral blood
from secondary transplanted mice was analyzed at 4, 8, and 12 weeks after
transplantation. Thirteen weeks after transplantation, mice were killed and
analyzed for reconstitution in BM, thymus, and spleen.
In vitro methylcellulose colony assays
For methylcellulose colony assays, FL cell suspensions were prepared in
Iscove modified Dulbecco medium (IMDM) supplemented with 2% FBS.
CFU-C and CFU-E assays were performed with MethoCult M3434
(containing rmSCF 50 ng/mL, rmIL-3 10 ng/mL, rhIL-6 10 ng/mL, and
rhEPO 3 U/mL) or M3334 (containing rhEPO 3 U/mL), respectively, (from
StemCell Technologies, Grenoble, France) in 35-mm dishes accordingly to
manufacturer’s instructions. All assays were done in triplicate. Colonies
( 30 cells) were counted after 7 days (CFU-C) or 3 days (CFU-E) of
incubation at 37°C, 5% CO2 and humidified atmosphere. CFU-Mix were
defined as colonies containing at least 3 different cell types. May-Grunwald
Giemsa stainings were performed to confirm identification of the colonies
by morphology.
Cocultures of FL cells with OP9 bone marrow stromal cell line
Total FL cells were cultured in RPMI-1640 medium supplemented with
10% FBS, mrIL-7 (10 ng/mL) and mrSCF (50 ng/mL; both from R&D
Systems, Minneapolis, MN), for 24 hours to separate FL stroma from
hematopoietic cells. Ten thousand to 50 000 cells were then cultured on
confluent layers of the OP9 BM stromal cell line in MEM medium, also
supplemented with FBS, mrIL-7, and mrSCF. After 7 to 16 days of
incubation at 37°C, cells were harvested and stained for flow cytometry.
Histology and immunohistochemistry
Six-m tissue sections of frozen E12.5 embryos were fixed in acetone. For
visualization of the different organ structures, sections were stained with
hematoxylin-eosin (HE). To envisage thymic epithelium, sections were
incubated with concentrated supernatant from a hybridoma producing the
ER-TR4 antibody for thymic stromal cells, followed by a biotinylated
rabbit anti-rat antibody (Dako, Glostrup, Denmark) and finally with
avidin-biotin complex–horseradish peroxidase (Dako). Sections were incu-
bated with 3-amino-9-ethylcarbazole (AEC) substrate (Dako) to detect
peroxidase.
Fetal thymic organ culture
Fetal thymic lobes from Wt and Wnt3a/ E12.5 embryos were isolated and
cultured on the top of a filter floating on medium (IMDM, 10% FBS). After
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9 to 17 days of culture, cells were harvested and analyzed by flow
cytometry.
Results
Reduced numbers of HSCs in Wnt3a/ E12.5 embryos
The loss of Wnt3a leads to embryonic lethality around E12.5.
Wnt3a/ embryos harbor a severe phenotype with little or no
caudal development posterior to forelimbs, disrupted notochord,
and abnormal formation of ectopic neural tubes.15 After E12.5,
recovery of viable Wnt3a/ embryos dramatically decreases, and
therefore heterozygous mice were bred and the embryos analyzed
at this age.
At E12.5 the FL is the major hematopoietic organ, which is
colonized by progenitors from aorta-gonad-mesonephros (AGM) re-
gion, yolk sac and placenta, starting by late E9.21 The FLs from
Wnt3a/ and Wt embryos did not differ in the total cell numbers
(2.86 106	 1.28 106 in Wnt3a/ and 3.32 106	 1.25 106
in Wt FLs; p
 .54) and the total percentage of leukocytes (as
determined by CD45 expression) did also not differ between Wt and
Wnt3a/ FLs (data not shown). Besides this, FLs were red, suggesting
that the embryos were not anemic.
Murine HSCs are found in a rare population characterized by
the absence of lineage markers and expression of Sca1 and c-Kit,
the so-called LSKs (Lin Sca1 c-Kit).22 Analysis of this
population in the FLs from Wnt3a/ embryos showed a marked
reduction in the percentage of these cells (3- to 5-fold) comparing
to Wt (Figure 1A,B). While in agreement with previous reports the
Wt FLs contained 0.51% LSK, the Wnt3a/ FLs contained only
0.15% LSKs on average.
Different studies have shown that up-regulation of Flt3/Flk2
expression is accompanied by loss of HSC long-term reconstitution
capacity in BM and FL.23-25 The analysis of the Flt3 (HSCs) and
Flt3 (multipotent progenitors; MPP) subsets within the LSK
population revealed that, although the Flt3 subset was more
severely affected, both populations were strongly decreased indicat-
ing a HSC deficiency (Figure 1C,D). This quantitative difference
led to a difference in actual stem cell–dependent repopulation of
recipient mice. That is, when different numbers of E12.5 FL cells
from Wt or Wnt3a/ embryos were transplanted into sublethally
irradiated recipients (6Gy), only the highest number of Wnt3a/
cells (4  106) could repopulate ( 1% donor contribution in
peripheral blood) 3 of 3 recipient mice. By contrast, a 16-fold lower
number of Wt cells transplanted (0.25  106 cells) was able to
repopulate 2 of 6 recipient mice (Table 1), while none of the mice
(0 of 6) that received Wnt3a/ cells showed donor-derived
reconstitution.
HSC self-renewal is irreversibly impaired
To test whether besides a severe quantitative reduction in HSC,
these cells were also affected in their function, we performed
competitive transplantation assays. For this, 400 LSKs isolated by
cell sorting from Wt or Wnt3a/ FLs (Ly5.2) were mixed with
2.5  105 Wt total FL cells (Ly5.1), which were measured to also
contain around 400 LSK, to have an approximately 1:1 competi-
tion. The cell mixtures were intravenously injected into Wt Ly5.1
recipient mice that were lethally irradiated. The chimerism was
followed in peripheral blood at 4, 8, 10, and 12 weeks after
transplantation. Both Wt and Wnt3a/ cells were able to repopu-
late the primary recipients with comparable efficiency (7 of 8 mice
repopulated  1% with Wt cells and 3/4 mice repopulated with
Wnt3a/ cells; Figure 2A). Besides this, 12 weeks after the
beginning of the experiment, the analysis of BM of repopulated
mice showed no significant difference in the percentage of total
Ly5.2 (Figure 2B,C) and in the contribution toward the different
lineages (data not shown). Analysis of the HSC compartment
revealed a nonstatistically significant reduction in the frequency
Figure 1. Wnt3a deficiency leads to a severe reduction in HSC (LSK Flt3) and multipotent progenitor (MPP, LSK Flt3) numbers. (A) Flow cytometry analysis of LSK
(Lin Sca1 c-Kit) population in Wt and Wnt3a/ FLs from E12.5 embryos. Lineage negative cells were electronically gated and analyzed for Sca1 and c-Kit expression.
Percentage of Sca1c-Kit cells is indicated. (B) Percentage of LSK cells in total FL is strongly decreased. Data are from 16 Wt and 11 Wnt3a/ FLs, belonging to 6 different
litters identified by different colors. Mean values are presented as a dash. (C) Flow cytometry analysis of the Flt3 subsets in the LSK compartment. LSKs were electronically
gated and analyzed for Flt3 expression. Percentages of FltL3 (HSCs) and Flt3 (MPPs) cells are indicated. (D) Frequency of Flt3 and Flt3 LSK cells in total FL. Data are
from 16 Wt and 11 Wnt3a/ FLs, belonging to 6 different litters identified by different colors. Mean values are presented as a dash. P values are indicated in all graphs.
Table1. Total FL cell suspensions from embryonic day 12.5 Wt or
Wnt3a/ embryos (Ly5.2) were prepared and the indicated
numbers of cells were intravenously injected into sublethally
irradiated Ly5.1 recipient mice
E12.5 FL
cells/mouse
Repopulated mice
Wt Wnt3a/
0.25  106 2/6* (33%)† 0/6 (0%)
1  106 3/5 (60%) 0/3 (0%)
4  106 4/4 (100%) 3/3 (100%)
Multilineage repopulation was confirmed by flow cytometry for all repopulated
animals.
*Number of repopulated mice ( 1% in peripheral blood) 12 weeks after
transplantation per total number of mice receiving a transplantation.
†Correspondent frequencies of repopulated animals.
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of Ly5.2 LSKs in the BM of mice receiving Wnt3a/ cells (Figure
2D). Flt3 and Flt3 subsets within LSK compartment did not
differ between the mice receiving Wt or Wnt3a/ LSKs (data
not shown).
However, when total BM cells from the primary recipient mice
were retransplanted into lethally irradiated Wt secondary recipi-
ents, the repopulation capacity measured in peripheral blood was
severely reduced in mice receiving Wnt3a/ cells, as early as
4 weeks after transplantation (Figure 3A). Furthermore, the contri-
bution toward different lineages was strongly affected in the
secondary recipients receiving Wnt3a/ cells (Figure 3B). Analy-
sis of the repopulation efficiency in BM 13 weeks after transplanta-
tion showed an average contribution of 60% in the mice that
received retransplanted Wt cells whereas in the mice receiving
retransplanted Wnt3a/ cells this was reduced more than 15-fold
(4% chimerism on average; Figure 3C,D). Moreover, although the
total percentage of LSKs did not differ in the mice receiving
Wnt3a/ cells, this population mainly consisted of cells express-
ing the congenic marker Ly5.1, while around 70% (average) of the
LSKs from the Wt mice group expressed the Ly5.2 marker (Figure
3E,F). The analysis performed in other hematopoietic organs
such as thymus and spleen showed similar differences (data not
Figure 2. Wnt3a/ LSKs efficiently repopulate primary recipient mice in competitive assays. Lethally irradiated Ly5.1 mice were transplanted with sorted LSK cells
(Ly5.2), from Wt or Wnt3a/ FLs, together with unfractionated FL cells (Ly5.1), to have a competition of approximately 1:1. (A) Repopulation efficiency (percentage of Ly5.2
cells) was analyzed in peripheral blood at the indicated time points. Graph shows mean plus or minus SD of 7 and 3 mice that received Wt and Wnt3a/ LSKs, respectively.
(B) Repopulation efficiency (percentage of Ly5.2 cells) was analyzed in BM of recipient mice at 12 weeks. Numbers in quadrants indicate the percentage of total Ly5.1 or Ly5.2
cells. (C) Analysis of the HSC compartment. Lin Ly5.2 cells were electronically gated and analyzed for Sca1 and c-Kit to define LSK population. (D) Percentage of Ly5.2 LSK
cells in total BM of the recipient mice. Data are mean plus or minus SD of 7 mice repopulated with Wt cells and 3 mice repopulated with Wnt3a/ cells. Results are
representative of 3 independent experiments.
Figure 3. Wnt3a/ HSC have severely reduced long-term repopulation capacity as revealed by failure to repopulate secondary recipients. Total BM cells from
primary recipient mice were retransplanted into lethally irradiated secondary Ly5.1 recipients. (A) Repopulation efficiency was analyzed in peripheral blood at the indicated time
points. (B) Ly5.2 LSKs contribution toward myeloid (CD11b), B-lymphoid (CD19) and T-Lymphoid (CD3) lineages measured in peripheral blood at the indicated time points.
(A,B) Graphs show mean plus or minus SD of 7 mice in each group (Wt and Wnt3a/). (C) Thirteen weeks after transplantation repopulation was analyzed in the
hematopoietic organs. Numbers in quadrants indicate the percentage of total Ly5.1 or Ly5.2 cells in the BM of the recipient mice. CD45.1CD45.2 double negative cells
constitute erythrocytes and megakaryocytes. (D) Percentage of total Ly5.2 cells in the BM of the recipient mice. The averages are indicated by a dash. (E) HSC compartment
analysis in the secondary recipient mice. LSK cells were gated and analyzed for Ly5.2 expression. (F) Frequency of Ly5.2 LSK cells in the BM of the recipient mice. The
averages are indicated by a dash. (C-F) Data represent 7 mice in each group. P values are indicated in the graphs. Results are representative of 3 independent experiments.
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shown). Thus, secondary transplantations revealed strongly
reduced reconstitution by Wnt3a/ HSCs, showing that these
cells have extremely limited self-renewal capacity. Importantly,
although being transplanted into Wt recipient mice, in which
Wnt3a is abundantly expressed in BM,16 the LSK cells had very
low repopulation efficiency, indicating a permanent and irrevers-
ible self-renewal deficiency.
Wnt3a/ HSC have normal differentiation capacity
At E12.5, FL hematopoiesis is mainly directed toward erythrocyte
production, with around 95% of the cells constituting erythroid
progenitors. Analysis of the different stages of erythroid develop-
ment using the erythroid-specific marker Ter119 and the transferrin
receptor CD7126 together with the progenitor marker c-Kit, showed
no significant differences between Wt and Wnt3a/ FLs, indicat-
ing normal erythroid development (data not shown). Analysis of
the nonerythroid lineages (CD71Ter119) showed that in the
Wnt3a/ livers the B220 cells were also present in a similar
frequency as in Wt embryos. However, total CD11b myeloid cells
were slightly reduced (P 
 .01) in the livers from Wnt3a/
embryos (Figure 4A,B). Nevertheless this reduction was not
observed in the more mature CD11bF4/80 subset of myeloid
cells, but it was due to a marked reduction in more immature
CD11bF4/80 myeloid cells (Figure 4A,B), suggesting a progeni-
tor deficiency that does not impair terminal differentiation.
Reduced numbers of myeloid but not B-lymphoid progenitors
The decreased frequency of more immature myeloid cells, together
with the strong reduction of MPPs indicated that Wnt3a deficiency
is affecting not only HSC self-renewal but also primitive progeni-
tors subsets.
To further investigate a possible deficiency in myeloid progeni-
tors, in vitro methylcellulose colony-forming assays were per-
formed. Interestingly, in the presence of multiple cytokines,
compared with wild-type cells, the Wnt3a/ FL cells consistently
yielded  3-fold fewer colonies (Figure 4C). Of interest, the
relative frequency of the different types of colonies was also
different between the Wt and Wnt3a/ cells (Figure 4D). Wnt3a/
FL cells yielded a lower number of CFU-Mix leading to a 6-fold
reduction in the absolute numbers of these colonies. Besides this,
also CFU-GM and BFU-E colonies appeared slightly reduced. In
agreement with what was previously observed, absolute numbers
of CFU-G and -M were not significantly different, indicating that
more mature myeloid cells were produced at normal frequencies.
Figure 4. Wnt3a deficiency affects myeloid progenitors without impairing terminal differentiation. (A) E12.5 Wnt3a/ livers show decreased frequency of myeloid
CD11b (Mac1) and CD11b F4/80 immature subsets, accessed by flow cytometric analysis. Numbers in quadrants denote frequencies of cells gated as indicated.
(B) Frequency of CD11b myeloid cells and F4/80 (/) subsets in total FL. Data are mean plus or minus SD of 5 Wt and 4 Wnt3a/ FLs, from 3 different litters. (C) Numbers
of colonies yielded by Wt and Wnt3a/ FLs in methilcelulose colony assays. Data are mean plus or minus SD of 6 Wt and 3 Wnt3a/ FLs, from 3 different litters, done in
triplicate. P 
 3.9  104. (D) Relative frequency of the different colonies determined by morphologic analysis and confirmed by staining with May-Grunwald Giemsa. Data are
representative of 4 Wt and 3 Wnt3a/ FLs, from 3 different litters. M, Macrophage; G, granulocyte; BFU-E, burst forming unit-erythrocyte; Mix, mixed (containing at least
3 different types of cells). (E) Erythroid colony-forming unit (CFU-E) assay of Wt and Wnt3a/ FLs cells. Data are mean plus or minus SD of 5 Wt and 4 Wnt3a/ FLs, from
3 different litters, done in triplicate. (F) Flow cytometry analysis of myeloid progenitor subsets in the FL of Wt and Wnt3a/ embryos. Lineage-negative cells were electronically
gated and analyzed for c-Kit, Sca1 and IL-7R expression. c-Kit Sca1 IL-7R cells were then analyzed for CD34 and FcR II/III expression. Numbers next to outlined areas
indicate the percentage of cells in each progenitor subset (CMP-FcRlo CD34; GMP-FcRhi CD34; MEP-FcRlo CD34). (G) Frequency of CMPs, GMPs, and MEPs in total
FL. The averages are indicated by a dash. Data from 11 Wt and 6 Wnt3a/ FLs, belonging to 6 different litters identified by different colors. P values are indicated.
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Total number of CFU-E colonies was not significantly altered
(Figure 4E). This was confirmed by flow cytometric analysis of the
different myeloid progenitor subsets.27 Both common myeloid
progenitors (CMPs; FcRloCD34) and granulocyte-monocyte-
progenitors (GMPs; FcRhiCD34) frequencies in Wnt3a/ FLs
were severely reduced. Megakaryocyte-erythrocyte progenitors
(MEPs; FcRloCD34) were not affected (Figure 4F,G).
Wnt3a has been proposed to function as a growth factor for pro-B
cells when provided as a prototype Wnt in vitro.16 Moreover, the severe
reduction in the numbers of MPPs suggested that Wnt3a/ primitive
progenitors might have reduced lymphoid potential.
Surprisingly, the analysis of the FL counterpart of adult
common lymphoid progenitor (CLP), which is phenotypically
similar (LinIL-7Rc-KitloSca1lo) and is present as a distinct
population at E12.5,28 did not reveal any difference between Wt
and Wnt3a/ FLs, although there is a nonsignificant trend toward
lower numbers of CLP in Wnt3a/ embryos (Figure 5A,B).
Furthermore, after 7 days of culture on OP9 BM-derived stromal
cells, both Wt or Wnt3a/ E12.5 FL cells efficiently developed
into CD19 B-cell progenitors (Figure 5C). Most cells were in the
pro–B-cell stage, but after prolonged culturing intracellular IgM
could be detected both in the cultures using Wt or Wnt3a/ cells
(data not shown). After 7 days of culturing, the percentage of
CD19 cells was significantly higher in the Wnt3a/ cultures, but
this increase was not reflected by an absolute increase in cell
numbers. Rather it was attributed to the marked reduction of the
CD11b population, confirming that Wnt3a deficiency negatively
affects myeloid differentiation.
We were also interested in the capacity of Wnt3a/ progenitors
to seed the thymus and differentiate into the T-cell lineage. In the
developing mouse embryo, the thymic rudiment is first colonized
by immature cells at approximately E11.21 Because thymic lobes at
E12.5 are not yet well-defined structures, sections were prepared
and stained with HE to visualize different tissues. Presence of a
thymic rudiment could be demonstrated in Wnt3a/ embryos and
was confirmed by staining with ER-TR4, which identifies thymic
epithelial cells29 (Figure 5D). Although the thymic rudiment is
seeded by hematopoietic cells, in Wnt3a/ embryos it shows a
noticeable reduction in size indicating that T-cell development is
affected with respect to cell numbers. To further characterize this
deficiency, explant cultures of E12.5 thymic lobes (fetal thymic
organ culture [FTOC]) were performed. In general, Wnt3a/
thymi were found to contain fewer thymocytes (usually about
3-fold lower) than Wt embryos, irrespective of the duration of
culturing (data not shown). After 9 days of culturing, all stages of
T-cell development could be distinguished, including mature single
positive (SP) CD4 and CD8 cells, both in Wt and Wnt3a/
embryos (Figure 5E). At this time point, no differences were
detected in subset distribution between Wt and Wnt3a/ thymi.
However, when thymic lobes were cultured for prolonged times
(14-17 days), T-cell development in Wnt3a/ thymi rapidly
deteriorated. This presented mainly as a decrease in the percentage
of double-positive (DP) cells and an accumulation of CD8
thymocytes, revealing a block at the ISP stage (Figure 5E). The
progressively impaired T-cell development at the ISP stage pheno-
copies mice deficient in Tcf1,30 suggesting that the Wnt3a effects on
immature thymocytes are mediated by signaling through Tcf1. To
investigate whether this defect is intrinsic to the hematopoietic
cells that seeded the thymus, we cultured Wt and Wnt3a/ E12.5
FL cells in irradiated thymic lobes from Wt E14.5 embryos. After
14 to 21 days of culture, lobes were stained for flow cytometry. No
differences were observed between FTOCs using Wt or Wnt3a/
FL cells, with respect to cell numbers or thymocyte subset
distribution (data not shown). The reduced T-cell development in
Wnt3a/ embryos must therefore be attributed to absence of
Wnt3a production by the thymic stroma.
Wnt3a deficiency does not alter survival or cell cycle of
hematopoietic stem and progenitor cells
Wnt3a/ HSCs have impaired long-term repopulation capacity but
have largely retained the ability to develop into all hematopoietic
Figure 5. Lymphoid potential of Wnt3a/ hematopoi-
etic progenitors. (A) Flow cytometric analysis of com-
mon lymphocyte progenitors (CLPs). Lineage-negative
IL-7R cells were gated and analyzed for c-Kit and Sca1
expression. Numbers indicate the percentage of cells in
each gate. (B) Percentage of CLPs in total FLs from Wt
and Wnt3a/ embryos. The averages are indicated by a
dash. Data from 11 Wt and 6 Wnt3a/ FLs, belonging to
6 different litters identified by different colors. (C) To
evaluate B-cell potential Wt and Wnt3a/ FL cells were
cultured for 7 days on confluent layers of OP9 BM derived
stromal cells. Cells were harvested and presence of cells
from different lineages was analyzed by flow cytometry.
Data are representative of 4 independent experiments.
(D) Reduced cellularity in Wnt3a/ thymic anlage re-
vealed by immunohistochemistry analysis. Tissue sec-
tions of E12.5 embryos were stained with HE to visualize
different tissues (left panels). Thymic epithelial cells
stained with the thymic stroma antibody ER-TR4 (right
panels) to confirm identification of thymic anlage in
Wnt3a/ embryos. Staining with an isotype control for
ER-TR4 was completely blank. Thymic anlage is indi-
cated by . Stainings shown are representative of 4 Wt
and 4 Wnt3a/ embryos examined. (E) Thymic lobes
from Wt and Wnt3a/ E12.5 embryos were cultured in
FTOC to allow T-cell development to proceed, and
harvested at the indicated time points. Thymocytes sub-
sets were analyzed by flow cytometry. Data are from
5 Wt and 3 Wnt3a/ embryos analyzed.
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lineages. We next sought to study the cellular basis underlying this
self-renewal defect.
HSC function depends on a tight regulation of the cell cycle. It
was recently shown that activation of -catenin leads to an
increased proliferation followed by loss of stem cell activity and
exhaustion of the HSC pool.8,9 We therefore analyzed the cell-cycle
status of the HSC compartment. A high proportion of the LSK cells
in the Wt FL are in cycle22 in agreement with FL being an organ
where expansion of the HSC compartment occurs. No significant
differences were found in the frequency of LSK cells in S/G2/M
suggesting that Wnt3a deficiency has no effect on the HSCs
proliferation (Figure 6A). Furthermore, to investigate whether
LSKs from Wnt3a/ embryos have decreased survival capacity,
we analyzed apoptosis in these cells. In Wt and Wnt3a/ LSK
compartments, the frequency of annexin V cells did not differ
(Figure 6B) indicating comparable apoptosis levels.
We also wanted to analyze whether Wnt3a deficiency differen-
tially affected activation of the Notch-signaling pathway because
this has been shown to be important for HSC function and has been
proposed to collaborate with Wnt signaling to maintain stem cell
properties.31 However using a specific antibody against activated
Notch1 no differences were detected in the activation of this
pathway in Wnt3a/ comparing to Wt LSKs (Figure 6C).
Thus, neither alteration in cell cycle nor in survival of stem/
progenitor cells explains the reduced numbers of cells and de-
creased long-term repopulation capacity. Furthermore, differential
activation of Notch1 was also not observed.
Discussion
Using a mouse model that lacks expression of Wnt3a, we show
here that the deficiency of one specific Wnt protein leads to
markedly reduced numbers of HSCs in vivo. These HSCs were not
affected in multilineage differentiation potential but they had an
irreversible and severely decreased self-renewal and long-term
repopulation capacity, as determined by secondary transplantation
assays. The absence of Wnt3a also strongly affects the primitive
MPP progenitors and more mature myeloid progenitors such as
CMPs and GMPs that were decreased in number. By contrast CLPs
and precursor B cells were not affected.
Because MPPs retain both myeloid and lymphoid potentials but
little or no erythroid-megakaryocyte potential,24,32,33 one could
expect both myeloid and lymphoid progenitors to be affected. The
fact that CMPs are severely reduced while CLP appeared not to be
affected shows a stronger dependency on Wnt3a for myeloid versus
B-lymphoid development. This is also supported by the strict
dependence on Wnt–-catenin signaling for the progression of
chronic myelogenous leukemias whereas B-cell acute lymphoblas-
tic leukemias can develop independently of -catenin expression.13
Despite this deficiency at the progenitor level, mature myeloid cells
were present at normal numbers. This can be explained by the fact
that the defects observed do not completely block differentiation
and because lineage-specific progenitors can probably compensate
for the early incomplete differentiation block by rapid and exten-
sive proliferation supported by cytokines that act in a lineage
specific fashion, such as GM-, G- and M-CSF, as well as IL-7.
By means of coculture of FL progenitors with a BM derived
stromal cell line, no defects in B-cell development were observed.
It was previously shown that B-cell development in Lef1/ mice is
partially blocked at the pro–B-cell stage due to lack of Wnt-
dependent proliferation.16 In agreement with this, Wnt5a was
shown to negatively regulate proliferation of early B cells, possibly
by inhibiting canonical-Wnt target genes.34 Although recombinant
Wnt3a was shown to induce this proliferation in vitro,16 it is likely
that Wnt3a is not the physiologically relevant Wnt for pro–B-cell
proliferation or other Wnt proteins are compensating this function,
as our data do not show a block in B-cell development. This is
consistent with the idea that HSCs and precursor B cells occupy
different niches.
In contrast, the T-cell lineage shows clear defects, probably
reflecting the dependency of the early thymic emigrants on MPP as
a major physiological precursor cell to the first cell that seeds the
thymus.35 The progressively impaired T-cell development at the
ISP stage observed phenocopies mice deficient in Tcf130 suggesting
that in these mice T-cell development is blocked because of lack of
a nuclear response to proliferative Wnt signals, as has also been
suggested by previous loss-36,37 and gain-of-function studies.38 This
phenotype appears to be environmentally determined, because
Wnt3a/ cells develop normally in Wt FTOCs. This is supported
by the expression of Wnt3a in thymic epithelium, but not in the
developing thymocytes.17 The similarities with Tcf1 deficiency
suggest that Wnt3a is directly regulating thymocyte development,
but it is possible that Wnt3a is also important for the thymic stroma
and consequently affects T-cell development. Nevertheless, there
appears to be an important difference in the function of Wnt3a for
immature thymocytes, where it seems to be mainly a proliferation
factor, versus HSCs where it influences self-renewal and differen-
tiation cell fates
The Wnt3a deficiency does not only lead to a quantitative defect in
HSC numbers, but Wnt3a/ HSCs are also functionally affected.
Although they are able to efficiently repopulate lethally irradiated
Figure 6. Long-term repopulation deficiency is not
caused by altered cell cycle or survival. (A) Cell-cycle
analysis (Hoechst 33342) of E12.5 FL LSKs from Wt and
Wnt3a/ embryos. Values represent percentage of LSK
cells in S/G2/M phases of the cell cycle. Results are
representative of 3 Wnt3a/ and 6 Wt embryos from
3 different litters. (B) Determination of percentage of
apoptotic cells by staining with annexin V and 7AAD.
Apoptotic cells were defined as annexin V 7AAD.
Results are representative of 6 Wnt3a/ and 6 Wt
embryos from 2 different litters. (C) Activation of Notch1
in E12.5 FL LSKs from Wt and Wnt3a/ embryos.
Results are representative of 4 Wnt3a/ and 8 Wt
embryos belonging to 4 different litters.
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primary recipients, long-term reconstitution capacity is markedly re-
duced when HSCs are rechallenged by transplantation into secondary
recipient mice, demonstrating a lack in self-renewal capacity.
Because Wnt3a is a secreted factor it might affect HSCs directly
or indirectly by signaling through the stromal cells39 that constitute
the HSC niche. Thus, this environmentally determined deficiency
turns into a cell-autonomous defect as Wnt3a in BM of the Wt
recipient mice is not able to restore normal HSC function. This
indicates that lack of Wnt3a during a critical period in embryonic
development irreversibly impairs the self-renewal capacity of
HSCs, suggesting that Wnt3a is important for the establishment of
a specific genetic program in HSCs. A similar phenotype was
observed in adult HSCs when they transiently occupied a niche that
overexpressed the Wnt inhibitor Dkk1.40 Furthermore, the in-
creased B-cell proliferation observed in Wnt5a-deficient FLs also
could not be complemented by physiologic levels of Wnt5a
expressed by Wt BM stroma.34 The irreversible Wnt3a/ pheno-
type could possibly be explained by epigenetic alterations induced
by Wnt signals. Indeed, different members of the Polycomb
complex factors were shown to be essential for HSCs function.41,42
More specifically, Rae28 deficiency results in reduced fetal HSC
and progenitor numbers, while FL cellularity and mature cell
subsets remained unaffected,42 similarly to what we observed here.
Several lines of evidence suggest that Wnt activity is context
dependent. Wnt proteins have different effects depending on the
target cell,34 receptor availability,43 and probably other signals or
pathways activated at the same time.6,44 In this way, approaches to
generally activate or ablate Wnt signaling may lose the regulatory
mechanisms between different Wnts. Indeed different -catenin
gain-of-function studies yielded different results probably reflect-
ing the effect of different dosages of activation of the pathway.6,8,9
The notion that correct levels of Wnt signaling are critical in
inducing a self-renewal type of expansion in HSC45 is also
supported by experiments from Baba et al,46,47 who showed that it
is possible to induce some stem cell characteristics in committed
progenitors by ectopic expression of stable -catenin. However,
such progenitors did not reconstitute T cells when transplanted to
immunodeficient mice, showing again that a very strong signal that
bypasses all negative regulatory steps of the Wnt-signaling cascade
such as given by stabilized -catenin cannot mimic events trig-
gered by tightly regulated physiological Wnt signals. Although
initial studies failed to show a phenotype in the absence of
-catenin,10-12 2 recent loss of function approaches by knocking out
-catenin13 or overexpressing Dkk1,40 thereby inhibiting canonical
Wnt signaling, showed reduced self-renewal capacity of HSCs.
Here we were able to point one specific Wnt protein in this
function, at least during embryonic development.
The reduced number of HSC and reduced long-term repopula-
tion capacity observed could not be explained by alterations in cell
cycle or survival of stem/progenitor cells. In this way, HSCs from
Wnt3a/ embryos seem to be biased to a non–self-renewing type
of division leading to depletion of the HSC pool. Several develop-
mentally conserved signaling pathways, including Notch, Hedge-
hog and Smad pathways, appear to be important in the regulation of
HSC function48 and may normally collaborate with Wnt signaling
in establishing a self-renewal genetic program. One such candidate
is Notch signaling. However the levels of activated Notch1 did not
differ between Wt and Wnt3a/ LSK cells, making it unlikely that
Notch1 plays this role.
Interestingly, besides the similarities with Tcf1/Lef/ em-
bryos,18 the posterior patterning defects observed in the Wnt3a/
embryos also resemble the ones described for the Sox17/
embryos. Sox17 was recently shown to be a critical regulator of
fetal HSCs maintenance. Deletion of Sox17 leads to increased
levels of Dkk1 implying that it maintains fetal HSCs by promoting
Wnt signaling.49
We and others4 did not find Wnt3a expression at detectable
levels in the FL, probably because of Wnt3a expression is only
present a very restricted subset of niche cells. Nevertheless, this
might indicate that the deficiency we report here is determined
earlier during the embryonic development or in extrahepatic HSC
sources. Because the numbers of definitive HSCs in E12.5 FL
results from the cumulative HSC activity from the aorta-gonad-
mesonephros (AGM) region, yolk sac, and placenta,21,50 these
tissues warrant future study.
Given the differences between fetal and adult hematopoiesis, it
is also important to investigate whether Wnt3a plays similar roles
in the self-renewal of BM HSC. In view of the fact that Wnt3a is
expressed in BM,16 such a functional role would not be unexpected.
Finding specific Wnt proteins that regulate hematopoietic stem cell
fate may have important implications for in vitro manipulation and
expansion of the HSC compartment for transplantation and gene
therapy applications as well as for the understanding of cancer stem
cells in hematologic malignancies.
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